European Commission
Horizon-Miss-2026-02-Cancer-02 – Cancer Mission Ria
17:00:00 Brussels time
Last verified:
The Horizon-Miss-2026-02-Cancer-02 grant funds a single €15 million Research and Innovation Action (RIA) to advance cancer research under the European Commission's Cancer Mission 2026 call. Applicants must form a consortium of at least three entities across three different EU member states. This is a one-off call with single-stage evaluation, offering substantial funding for large-scale, coordinated cancer research initiatives across Europe.
Details
| Funder | European Commission |
| Budget | Around €15M per grant (total budget €15M) |
| Deadline | 15 September 2026 |
| Consortium | Required — minimum 3 entities from 3 EU member states |
| Application | Single stage |
| Frequency | One-off |
Eligibility & scope
Horizon Europe Research and Innovation Action under the Cancer Mission 2026 call. Single grant expected at approximately €15M. Full topic description available in the call portal.
Who Should Apply
- •Research institutions, hospitals, and universities across EU member states
- •Consortia with partners from at least three different EU member states
- •Teams with expertise spanning fundamental, translational, and/or clinical cancer research
- •Organisations demonstrating capacity to deliver large-scale, coordinated research programmes
Key Dates
- •Deadline: 15 September 2026, 17:00 Brussels time
- •Single-stage written evaluation
- •This is a one-off call; no recurrence is planned
Tips for Applicants
- ✓The consortium requirement is non-negotiable: all three member states must be distinct legal entities, not merely co-located teams; weak partnership governance is a common disqualifier.
- ✓Align your proposal to the Cancer Mission strategic priorities outlined in the call portal; generic cancer research without explicit mission alignment underperforms.
- ✓Budget narratives should justify the €15M scale with clear workpackage distribution and milestones; reviewers expect scientific ambition matched by credible resource planning.
Frequently Asked Questions
How much funding does the Horizon Cancer Mission 2026 call offer?
Approximately €15 million per grant, with one grant expected to be awarded.
Is consortium participation required for this call?
Yes, a minimum of three independent entities from three different EU member states must participate; single-institution or two-country bids are ineligible.
What is the deadline for the Horizon Cancer Mission 2026 call?
15 September 2026 at 17:00 Brussels time.
How many stages does the application process have?
Single-stage evaluation; all applications are assessed in one round without pre-proposal filtering.
Related on Grantsby
- European Commission writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from European Commission
Marie Sklodowska-Curie Actions (MSCA) Postdoctoral Fellowships 2026
Deadline: 9 Sept 2026Marie Skłodowska-Curie Actions Postdoctoral Fellowships (MSCA-PF) 2026
Deadline: 9 Sept 2026HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships (HORIZON-TMA-MSCA-PF-EF)
Deadline: 9 Sept 2026HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships (HORIZON-TMA-MSCA-PF-GF)
Deadline: 9 Sept 2026Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Deadline: 15 Sept 2026€7M–€8M per grant
Browse Related
Could Horizon-Miss-2026-02-Cancer-02 – Cancer Mission Ria be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →